a6407293.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 24, 2010

PHARMERICA CORPORATION
(Exact Name of Registrant as Specified in Its Charter)

     
Delaware
001-33380
87-0792558
(State or Other Jurisdiction
of Incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
 
 
1901 Campus Place
Louisville, Kentucky 40299
(Address of principal executive offices)  (Zip Code)

 
(502) 627-7000
(Registrant’s telephone number, including area code)
 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
     
o   
  
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
     
o   
  
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     
o   
  
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
     
o   
  
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
 
 

Item 8.01
Other Events.

On August 24, 2010, PharMerica Corporation (the “Company”) issued a press release announcing that its Board of Directors has authorized a share repurchase of up to $25 million of the Company’s common stock.  See press release attached as Exhibit 99.1


Item 9.01
Financial Statements and Exhibits.

(d) Exhibits

 
99.1
Press Release of PharMerica Corporation dated August 24, 2010.
 
 
 
 
 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 

 
PHARMERICA CORPORATION
     
Date: August 24, 2010
By:
/s/ Michael J. Culotta
   
Michael J. Culotta
   
Executive Vice President and Chief Financial Officer
 
 
 
 
 
Exhibit Index

Exhibit No.
Description
99.1
Press Release of PharMerica Corporation dated August 24, 2010.